Z-1778-2017 Class II Terminated

Recalled by Merge Healthcare, Inc. — Hartland, WI

FDA device recall Z-1778-2017 was initiated by Merge Healthcare, Inc. on Apr 4, 2016 and is designated Class II. Reason for recall: Use of the software may show an incorrect value to the user when viewing the Fractional Flow Reserve (FFR) results during recording. The recall status is terminated (terminated Feb 21, 2019). Affected quantity: 24 sites potentially have the affected versions.

Recall details

Product Type
Devices
Report Date
Apr 19, 2017
Initiation Date
Apr 4, 2016
Termination Date
Feb 21, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24 sites potentially have the affected versions

Product description

Merge Hemo software. The firm name on the labeling is Merge Healthcare, Hartland, WI. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure

Reason for recall

Use of the software may show an incorrect value to the user when viewing the Fractional Flow Reserve (FFR) results during recording.

Distribution pattern

Nationwide Distribution including AZ, CA, CO, FL, GA, KS, LA, MI, MO, OH, OK, TN, TX, VA, WA, WI, and WV.

Code information

Versions 9.10.0, 9.20.0, 9.20.1, 9.20.2, 9.30.3, and 9.40.0.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1778-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1778-2017. Report a data issue: hello@regdatalab.com.